Published in Nature on June 28, 2012
What we talk about when we talk about fat. Cell (2014) 4.12
PPARγ signaling and metabolism: the good, the bad and the future. Nat Med (2013) 3.71
Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 3.67
Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (2013) 3.64
Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell (2014) 3.22
A special population of regulatory T cells potentiates muscle repair. Cell (2013) 3.09
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (2013) 2.85
A Distinct Function of Regulatory T Cells in Tissue Protection. Cell (2015) 2.78
Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science (2015) 2.73
Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity (2014) 2.63
Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol (2013) 2.47
A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes. Immunity (2015) 2.35
T cell metabolism drives immunity. J Exp Med (2015) 2.06
Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. Cell (2017) 2.03
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells. Science (2015) 1.95
Immunological goings-on in visceral adipose tissue. Cell Metab (2013) 1.84
Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep (2014) 1.79
Regulatory T cells in nonlymphoid tissues. Nat Immunol (2013) 1.69
Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature (2015) 1.68
An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell (2015) 1.63
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta (2013) 1.60
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity (2014) 1.57
Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells. Immunity (2016) 1.54
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab (2014) 1.53
Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat Immunol (2014) 1.53
Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A (2016) 1.50
CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue. J Leukoc Biol (2015) 1.49
Control of inflammation by integration of environmental cues by regulatory T cells. J Clin Invest (2013) 1.43
PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications. Nat Commun (2016) 1.41
Systemic PPARγ deletion causes severe disturbance in fluid homeostasis in mice. Physiol Genomics (2015) 1.40
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity (2015) 1.34
Regulation of metabolism by the innate immune system. Nat Rev Endocrinol (2015) 1.29
RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab (2014) 1.28
Adipose tissue as an immunological organ. Obesity (Silver Spring) (2015) 1.27
Once a Treg, always a Treg? Immunol Rev (2014) 1.27
Metabolic control of the Treg/Th17 axis. Immunol Rev (2013) 1.26
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. Immunity (2016) 1.24
Peripherally induced tregs - role in immune homeostasis and autoimmunity. Front Immunol (2013) 1.24
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells. Immunity (2016) 1.21
Immune regulation of metabolic homeostasis in health and disease. Cell (2015) 1.21
Function of a Foxp3 cis-element in protecting regulatory T cell identity. Cell (2014) 1.19
Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. J Allergy Clin Immunol (2013) 1.19
Treg and CTLA-4: two intertwining pathways to immune tolerance. J Autoimmun (2013) 1.18
Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metab (2015) 1.14
Adipose tissue plasticity from WAT to BAT and in between. Biochim Biophys Acta (2013) 1.12
Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 1.11
Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol (2014) 1.11
Hallmarks of Tissue-Resident Lymphocytes. Cell (2016) 1.10
Interactions between innate and adaptive lymphocytes. Nat Rev Immunol (2014) 1.08
GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling. Nat Immunol (2013) 1.06
Metabolic control of regulatory T cell development and function. Trends Immunol (2014) 1.06
Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells (2014) 1.05
Basic principles of tumor-associated regulatory T cell biology. Trends Immunol (2012) 1.05
Helios Controls a Limited Subset of Regulatory T Cell Functions. J Immunol (2015) 1.03
T follicular regulatory cells in the regulation of B cell responses. Trends Immunol (2015) 1.02
Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 1.02
An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep (2014) 1.02
The importance of regulatory T-cell heterogeneity in maintaining self-tolerance. Immunol Rev (2014) 1.02
Interindividual variation in human T regulatory cells. Proc Natl Acad Sci U S A (2014) 1.01
Role of T cells in malnutrition and obesity. Front Immunol (2014) 1.00
Control of Regulatory T Cell Migration, Function, and Homeostasis. J Immunol (2015) 1.00
Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes. Front Immunol (2013) 0.98
Synchronizing transcriptional control of T cell metabolism and function. Nat Rev Immunol (2015) 0.97
Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 0.96
Adipose tissue immunity and cancer. Front Physiol (2013) 0.96
Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology (2014) 0.95
Tissue Tregs. Annu Rev Immunol (2016) 0.94
Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors. PPAR Res (2013) 0.94
Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment. Front Endocrinol (Lausanne) (2013) 0.93
Inflammation, metaflammation and immunometabolic disorders. Nature (2017) 0.93
Comparative Transcriptome Analysis of Adipose Tissues Reveals that ECM-Receptor Interaction Is Involved in the Depot-Specific Adipogenesis in Cattle. PLoS One (2013) 0.91
Regulatory T cell identity: formation and maintenance. Trends Immunol (2015) 0.91
Human adipose dynamics and metabolic health. Ann N Y Acad Sci (2013) 0.90
The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes. Cell Res (2014) 0.90
Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis. Int J Mol Sci (2013) 0.89
Lipid metabolites as metabolic messengers in inter-organ communication. Trends Endocrinol Metab (2014) 0.89
Link between insulin resistance and hypertension: What is the evidence from evolutionary biology? Diabetol Metab Syndr (2014) 0.88
Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol (2014) 0.88
New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther (2013) 0.88
Molecular targets related to inflammation and insulin resistance and potential interventions. J Biomed Biotechnol (2012) 0.88
Role of adipokines signaling in the modulation of T cells function. Front Immunol (2013) 0.87
Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses. Proc Natl Acad Sci U S A (2013) 0.87
Tissue resident regulatory T cells: novel therapeutic targets for human disease. Cell Mol Immunol (2015) 0.87
B-1a lymphocytes attenuate insulin resistance. Diabetes (2014) 0.87
Control of brown and beige fat development. Nat Rev Mol Cell Biol (2016) 0.86
Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARγ effects. Proc Natl Acad Sci U S A (2014) 0.86
Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue. Arterioscler Thromb Vasc Biol (2013) 0.86
The interplay between regulatory T cells and metabolism in immune regulation. Oncoimmunology (2013) 0.86
Immunological contributions to adipose tissue homeostasis. Semin Immunol (2015) 0.86
Metabolic regulation of regulatory T cell development and function. Front Immunol (2014) 0.86
Obesity and metabolic inflammation. Drug Discov Today Dis Mech (2013) 0.85
Blood spotlight on leukocytes and obesity. Blood (2013) 0.85
Regulatory T cells turn pathogenic. Cell Mol Immunol (2015) 0.85
Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity. Cell Metab (2016) 0.85
New pathways to control inflammatory responses in adipose tissue. Curr Opin Pharmacol (2013) 0.85
Mapping the effects of drugs on the immune system. Nat Biotechnol (2015) 0.84
Inducing and Administering Tregs to Treat Human Disease. Front Immunol (2016) 0.84
Helminth infections, type-2 immune response, and metabolic syndrome. PLoS Pathog (2014) 0.84
B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukoc Biol (2014) 0.84
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol (2012) 9.75
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem (2008) 9.56
Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 8.15
PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell (1998) 7.91
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest (2007) 4.86
Muscle-specific Pparg deletion causes insulin resistance. Nat Med (2003) 3.93
Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med (2011) 2.74
PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci U S A (2009) 2.38
A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med (2011) 2.34
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A (2010) 2.10
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab (2004) 1.67
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Projection of an immunological self shadow within the thymus by the aire protein. Science (2002) 12.15
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell (2006) 9.24
Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 8.90
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med (2008) 6.07
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science (2002) 5.82
Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity (2007) 5.67
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med (2002) 5.09
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med (2004) 5.08
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
Stability of the regulatory T cell lineage in vivo. Science (2010) 4.89
The cellular mechanism of Aire control of T cell tolerance. Immunity (2005) 4.74
Aire. Annu Rev Immunol (2009) 4.43
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol (2009) 4.07
CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med (2004) 3.57
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55
Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science (2009) 3.47
Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J Immunol (2007) 3.47
Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity (2008) 3.25
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol (2002) 3.20
Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J Exp Med (2005) 3.14
A special population of regulatory T cells potentiates muscle repair. Cell (2013) 3.09
A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity (2005) 3.07
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med (2002) 2.98
Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med (2003) 2.94
Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med (2004) 2.92
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity (2011) 2.87
Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med (2007) 2.84
Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci U S A (2006) 2.83
Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science (2014) 2.77
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell (2013) 2.74
Aire's partners in the molecular control of immunological tolerance. Cell (2010) 2.68
Self-reactivity in thymic double-positive cells commits cells to a CD8 alpha alpha lineage with characteristics of innate immune cells. Nat Immunol (2004) 2.68
Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med (2005) 2.61
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood (2005) 2.55
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci (2008) 2.54
A decade of AIRE. Nat Rev Immunol (2007) 2.45
Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science (2006) 2.38
Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A (2010) 2.30
Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol (2012) 2.16
How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity (2009) 2.15
TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J Exp Med (2007) 2.15
Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol (2013) 2.13
Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol (2012) 2.11
Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc Natl Acad Sci U S A (2010) 2.09
Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med (2005) 2.08